Kenji Ikeda
#145,469
Most Influential Person Now
Kenji Ikeda's AcademicInfluence.com Rankings
Kenji Ikedamedical Degrees
Medical
#2734
World Rank
#3166
Historical Rank
Oncology
#175
World Rank
#181
Historical Rank
Kenji Ikedaphilosophy Degrees
Philosophy
#7807
World Rank
#11065
Historical Rank
Logic
#4842
World Rank
#6171
Historical Rank
Download Badge
Medical Philosophy
Kenji Ikeda's Degrees
- PhD Medical Science University of Tokyo
- Doctorate Medicine University of Tokyo
Why Is Kenji Ikeda Influential?
(Suggest an Edit or Addition)Kenji Ikeda's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial (2018) (2744)
- Gene expression in fixed tissues and outcome in hepatocellular carcinoma. (2008) (1158)
- Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. (2009) (900)
- A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis (1993) (725)
- The long‐term pathological evolution of chronic hepatitis C (1996) (650)
- Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection (2013) (618)
- Daclatasvir Plus Asunaprevir for Chronic HCV Genotype 1b Infection (2014) (538)
- Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long‐term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis (1999) (467)
- Factors predictive of response to interferon‐α therapy in hepatitis C virus infection (1994) (466)
- Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. (1998) (454)
- The long term efficacy of glycyrrhizin in chronic hepatitis C patients (1997) (406)
- Emergence and takeover of YMDD motif mutant hepatitis B virus during long‐term lamivudine therapy and re‐takeover by wild type after cessation of therapy (1998) (386)
- UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis (2017) (367)
- Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer (2000) (354)
- Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders (2012) (342)
- The Common and Distinct Features of Brown and Beige Adipocytes (2018) (327)
- Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. (2007) (281)
- Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy (2005) (276)
- Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C (2009) (274)
- Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin (2010) (273)
- Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma (2016) (255)
- Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma (1993) (251)
- Beige Adipocyte Maintenance Is Regulated by Autophagy-Induced Mitochondrial Clearance. (2016) (249)
- Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis (2000) (242)
- BCAA catabolism in brown fat controls energy homeostasis through SLC25A44 (2019) (241)
- Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma (2012) (238)
- Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options. (2013) (229)
- Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model (1991) (211)
- Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity–determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection (1997) (204)
- Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus (1998) (187)
- Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C (1991) (186)
- Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C (2013) (171)
- Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. (1994) (164)
- Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers (2011) (163)
- Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir. (2013) (162)
- Genotypic subtyping of hepatitis C virus (1993) (156)
- A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma (1996) (150)
- Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients. (2012) (144)
- Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis (2015) (144)
- Thermal stress induces glycolytic beige fat formation via a myogenic state (2018) (142)
- Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis (2014) (138)
- Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. (2007) (137)
- Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. (2006) (135)
- Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection. (1999) (133)
- Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis (2006) (130)
- Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan (2005) (124)
- The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. (2003) (123)
- Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection (2017) (123)
- Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. (1993) (118)
- CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling (2020) (116)
- Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis (2007) (114)
- Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b. (2012) (112)
- Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b (2007) (110)
- Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up. (2008) (107)
- Prognosis of hepatocellular carcinoma patients with extrahepatic metastases. (1997) (105)
- Repression of Adipose Tissue Fibrosis through a PRDM16-GTF2IRD1 Complex Improves Systemic Glucose Homeostasis. (2018) (104)
- Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw (2001) (104)
- Predictive factors of virological non‐response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load (2006) (101)
- Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection (2017) (100)
- REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset (2019) (99)
- Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir (2011) (98)
- Mitophagy controls beige adipocyte maintenance through a Parkin-dependent and UCP1-independent mechanism (2018) (98)
- Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B (2004) (93)
- Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non‐B, non‐C liver cirrhosis: a cohort study (2009) (92)
- Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads (2009) (92)
- Molecular analysis of intraspousal transmission of hepatitis C virus. (1995) (87)
- An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads (2009) (86)
- Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C (2004) (86)
- Efficacy of Lamivudine Therapy and Factors Associated with Emergence of Resistance in Chronic Hepatitis B Virus Infection in Japan (2003) (85)
- Effects of a sodium‐glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies (2017) (83)
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis Rate in Patients with Interferon-Resistant Active Chronic Hepatitis C: A Cohort Study of 1249 Patients (2006) (83)
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C (2002) (83)
- High serum des‐gamma‐carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma (2009) (82)
- Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2017) (82)
- UCP1 Dependent and Independent Thermogenesis in Brown and Beige Adipocytes (2020) (81)
- Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. (2001) (78)
- Psychiatric symptoms related to interferon therapy for chronic hepatitis C: Clinical features and prognosis (2000) (77)
- Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma (2017) (76)
- Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection (2004) (74)
- Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses (2017) (73)
- A matched case‐controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response (2009) (72)
- Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study (2014) (72)
- HBcrAg is a predictor of post‐treatment recurrence of hepatocellular carcinoma during antiviral therapy (2010) (70)
- Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. (2008) (69)
- Protective effects of lactoferrin against intestinal mucosal damage induced by lipopolysaccharide in human intestinal Caco-2 cells. (2008) (67)
- Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan (2002) (67)
- Diagnostic Problems Caused by HBsAg Mutants – A Consensus Report of an Expert Meeting (2004) (66)
- Diagnosis and follow‐up of small hepatocellular carcinoma with selective intraarterial digital subtraction angiography (1993) (65)
- Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients. (1999) (64)
- Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus (2019) (63)
- Association of amino acid sequence in the PKR‐eIF2 phosphorylation homology domain and response to interferon therapy (2000) (62)
- Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors. (2002) (61)
- Long-Term Outcome after Interferon Therapy in Elderly Patients with Chronic Hepatitis C (2006) (61)
- New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma (2010) (59)
- Factors useful in predicting the response to interferon therapy in chronic hepatitis C (1993) (59)
- Significance of Serum Ribavirin Concentration in Combination Therapy of Interferon and Ribavirin for Chronic Hepatitis C (2005) (59)
- Imaging diagnosis of small hepatocellular carcinoma (1994) (59)
- Natural history of compensated cirrhosis in the Child‐Pugh class a compared between 490 patients with hepatitis C and 167 with B virus infections (2006) (58)
- 14 DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN (2012) (57)
- Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia (2007) (57)
- Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1b (2018) (56)
- Early viral kinetics and treatment outcome in combination of high‐dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load (2005) (56)
- Impact of hepatitis B core‐related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues (2019) (56)
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study (2013) (55)
- Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy (2011) (55)
- Highly sensitive AFP‐L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre‐ and postoperatively (2011) (55)
- Recent advances in medical management of hepatocellular carcinoma (2018) (53)
- The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. (2011) (52)
- Difference in malignancies of chronic liver disease due to non‐alcoholic fatty liver disease or hepatitis C in Japanese elderly patients (2012) (51)
- Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy. (2002) (51)
- Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan (2017) (51)
- Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C (2000) (51)
- Long‐term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: A pilot study (2001) (48)
- Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. (2006) (48)
- Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. (2011) (47)
- Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus (2009) (47)
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001 (2004) (47)
- Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease (2009) (46)
- Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection. (1997) (46)
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update (2012) (46)
- Viral Dynamics and Pharmacokinetics in Combined Interferon Alfa-2b and Ribavirin Therapy for Patients Infected with Hepatitis C Virus of Genotype 1b and High Pretreatment Viral Load (2002) (46)
- Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis (2003) (45)
- Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis (2017) (45)
- Chronic liver disease in the extremely elderly of 80 years or more: clinical characteristics, prognosis and patient survival analysis. (1999) (45)
- Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients. (2008) (44)
- Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis (2012) (44)
- Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT). (2019) (44)
- Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis (2008) (42)
- Natural histories of hepatitis C virus infection in men and women simulated by the Markov model (2003) (42)
- Prolonged‐interferon therapy reduces hepatocarcinogenesis in aged‐patients with chronic hepatitis C (2007) (42)
- Change of hepatitis B virus genotypes in acute and chronic infections in Japan (2008) (41)
- Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease (2017) (41)
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus (2012) (40)
- Mitochondrial lipoylation integrates age-associated decline in brown fat thermogenesis (2019) (39)
- Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens (2017) (39)
- Serial hemodynamic measurements in well‐differentiated hepatocellular carcinomas (1995) (38)
- Effectiveness of combination therapy of splenectomy and long‐term interferon in patients with hepatitis C virus‐related cirrhosis and thrombocytopenia (2009) (38)
- Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon (2006) (38)
- Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome (2004) (38)
- The Influence of Histological Differentiation Grade on the Outcome of Liver Resection for Hepatocellular Carcinomas 2 cm or Smaller in Size (2015) (37)
- Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial (2014) (37)
- Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up (2014) (37)
- Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C. (1994) (37)
- HLA-DQB1*03 Confers Susceptibility to Chronic Hepatitis C in Japanese: A Genome-Wide Association Study (2013) (37)
- Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial (2017) (37)
- A Randomized Trial of Daclatasvir with Peginterferon Alfa-2B and Ribavirin for HCV Genotype 1 Infection (2014) (37)
- Risk factors of hepatitis C virus‐related liver cirrhosis in young adults: Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2) *0201 Allele (2001) (37)
- Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients (2013) (36)
- Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients. (2010) (36)
- A Prospective Randomized Evaluation of a Compound of Tegafur and Uracil as an Adjuvant Chemotherapy for Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization (1995) (36)
- Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus (2008) (36)
- YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine (2004) (35)
- Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan (2016) (35)
- Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older (2017) (34)
- Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter. (2005) (34)
- Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis (2007) (34)
- Postmortem analyses of drugs in pericardial fluid and bone marrow aspirate. (2013) (34)
- Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy (2011) (34)
- Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells. (2007) (34)
- Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H. (2007) (33)
- Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report (2007) (33)
- Clinical features of hepatitis B virus genotype A in Japanese patients (2003) (33)
- Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B (2014) (33)
- Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study (2016) (33)
- Recurrence Rate and Prognosis of Patients with Hepatocellular Carcinoma That Developed after Elimination of Hepatitis C Virus RNA by Interferon Therapy (2003) (32)
- Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers (2013) (32)
- Efficacy and safety in sitagliptin therapy for diabetes complicated by non‐alcoholic fatty liver disease (2013) (32)
- Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C. (2007) (31)
- Consistently Low Hepatitis B Virus DNA Saves Patients from Hepatocellular Carcinogenesis in HBV-Related Cirrhosis (2003) (31)
- Influence of Hepatitis C Virus Subtype on Hepatocellular Carcinogenesis: A Multivariate Analysis of a Retrospective Cohort of 593 Patients with Cirrhosis (2002) (31)
- Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN‐resistant cases with hepatocyte steatosis (2005) (31)
- Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha‐fetoprotein in patients without hepatocellular carcinoma (2008) (31)
- Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus (2010) (31)
- Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase. (2006) (31)
- Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 2a High Viral Load and Virological Response to Interferon-Ribavirin Combination Therapy (2009) (30)
- Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy (2002) (30)
- Emergence of telaprevir‐resistant variants detected by ultra‐deep sequencing after triple therapy in patients infected with HCV genotype 1 (2013) (30)
- Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT). (2019) (30)
- Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection. (2007) (29)
- Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction (1993) (29)
- Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary study (2001) (29)
- Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome (2017) (29)
- Anticarcinogenic Impact of Interferon on Patients with Chronic Hepatitis C: A Large-Scale Long-Term Study in a Single Center (2005) (29)
- Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan (2015) (29)
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection (2004) (29)
- Serum des‐gamma‐carboxyprothrombin concentration determined by the avidin‐biotin complex method in small hepatocellular carcinomas (1994) (29)
- Susceptibility of TT virus to interferon therapy. (1999) (29)
- Efficacy of Interferon Therapy in Elderly Patients with Chronic Hepatitis C (2006) (29)
- HEPATIC SQUAMOUS CELL CARCINOMA WITH HYPERCALCEMIA IN LIVER CIRRHOSIS (1988) (29)
- Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies (2016) (28)
- Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis (2020) (28)
- Genotype, slow decrease in virus titer during interferon treatment and high degree of sequence variability of hypervariable region are indicative of poor response to interferon treatment in patients with chronic hepatitis type C. (1995) (28)
- Glycyrrhizin injection therapy prevents hepatocellular carcinogenesis in patients with interferon‐resistant active chronic hepatitis C (2007) (28)
- Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan (2018) (28)
- Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma (2020) (28)
- Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b (2010) (28)
- Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone. (2008) (27)
- Long-Term Presence of HBV in the Sera of Chronic Hepatitis B Patients with HBsAg Seroclearance (2007) (27)
- Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayer. (1995) (27)
- Wireless optogenetics protects against obesity via stimulation of non-canonical fat thermogenesis (2020) (27)
- Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy (2003) (27)
- Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection (2005) (27)
- Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection (2006) (27)
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine (2003) (27)
- Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C (2006) (27)
- Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease. (2016) (27)
- Recent Progress in Radiofrequency Ablation Therapy for Hepatocellular Carcinoma (2014) (27)
- Stepwise Hook Extension Technique for Radiofrequency Ablation Therapy of Hepatocellular Carcinoma (2002) (26)
- Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma (2016) (26)
- Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus (2011) (26)
- Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir. (2010) (26)
- Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin (2009) (26)
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP‐424), pegylated interferon and ribavirin for 12 weeks (2009) (26)
- 18F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib (2019) (26)
- Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells. (1983) (25)
- Therapeutic effects of short‐ and intermediate‐term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis (2015) (25)
- Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin (2010) (25)
- Histological Improvements after a Three-Year Lamivudine Therapy in Patients with Chronic Hepatitis B in Whom YMDD Mutants Did Not or Did Develop (2003) (25)
- Prediction of Treatment Efficacy and Telaprevir-Resistant Variants after Triple Therapy in Patients Infected with Hepatitis C Virus Genotype 1 (2013) (25)
- Hepatic fat quantification using the two‐point Dixon method and fat color maps based on non‐alcoholic fatty liver disease activity score (2017) (24)
- Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals (2016) (24)
- Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients (2008) (24)
- Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection (2012) (24)
- Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan (2018) (24)
- Necessities of interferon therapy in elderly patients with chronic hepatitis C. (2009) (24)
- Wild‐type precore and core promoter sequences in patients with acute self‐limited or chronic hepatitis B (2004) (23)
- Hepatitis B Virus-Related Hepatocellular Carcinogenesis and Its Prevention (2005) (23)
- Development of HCC in patients receiving adefovir dipivoxil for lamivudine‐resistant hepatitis B virus mutants (2010) (23)
- Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort study. (2003) (23)
- Prevalence of TT virus before and after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma (1999) (23)
- A pilot study of corticosteroid priming for lymphoblastoid interferon alfa in patients with chronic hepatitis C (1996) (22)
- Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare‐up (2005) (22)
- Efficacy of entecavir treatment for lamivudine‐resistant hepatitis B over 3 years: Histological improvement or entecavir resistance? (2009) (22)
- The efficacy and safety of dual oral therapy with daclatasvir and asunaprevir for genotype 1b in Japanese real‐life settings (2017) (22)
- Hepatoblastoma in an 82‐Year‐old Man. An Autopsy Case Report (1990) (22)
- Long‐term entecavir therapy results in falls in serum hepatitis B surface antigen levels and seroclearance in nucleos(t)ide‐naïve chronic hepatitis B patients (2014) (22)
- Clinical and virological effects of long‐term (over 5 years) lamivudine therapy (2010) (21)
- Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: Long‐term follow up of a pilot study (2005) (21)
- In Hepatocellular Carcinomas, any Proportion of Poorly Differentiated Components is Associated with Poor Prognosis After Hepatectomy (2014) (21)
- Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: Multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival (2005) (21)
- Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma (2019) (21)
- Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. (2016) (21)
- Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections (2019) (21)
- A multicenter, open-label, phase 3 trial to compare the efficacy and safety of lenvatinib (E7080) versus sorafenib in first-line treatment of subjects with unresectable hepatocellular carcinoma. (2014) (21)
- Small hepatocellular carcinoma: evaluation of portal blood flow with CT during arterial portography performed with balloon occlusion of the hepatic artery. (1994) (21)
- Evolution of simeprevir‐resistant variants over time by ultra‐deep sequencing in HCV genotype 1b (2014) (21)
- Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection (2007) (20)
- Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma (2013) (20)
- Clinical and virological features of non‐breakthrough and severe exacerbation due to lamivudine‐resistant hepatitis B virus mutants (2006) (20)
- Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model (2011) (20)
- The major cap-binding protein eIF4E regulates lipid homeostasis and diet-induced obesity (2021) (20)
- Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen–positive asymptomatic healthy carriers (1998) (20)
- Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine (2007) (20)
- Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy (2011) (20)
- Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non‐responders infected with HCV genotype 1 (2012) (20)
- Amino Acid Substitution in HCV Core Region and Genetic Variation near the IL28B Gene Affect Viral Dynamics during Telaprevir, Peginterferon and Ribavirin Treatment (2012) (20)
- Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus. (2003) (19)
- Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan. (2013) (19)
- Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load (2003) (19)
- Potential of a no‐touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas (2017) (19)
- Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results Database (2019) (19)
- A prospective randomized administration of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization. (1997) (19)
- Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant (2001) (19)
- Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan (2012) (19)
- Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon‐alpha‐2b and ribavirin in hepatitis C patients (2013) (19)
- Virological and biochemical relapse according to YMDD motif mutant type during long‐term lamivudine monotherapy (2003) (19)
- Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance (2018) (18)
- Interferon Therapy for 2 Years or Longer Reduces the Incidence of Hepatocarcinogenesis in Patients with Chronic Hepatitis C Viral Infection (2004) (18)
- Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C (2006) (18)
- Fluctuations of hepatitis C virus load are not related to amino acid substitutions in hypervariable region 1 and interferon sensitivity determining region (1999) (18)
- Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load. (2010) (17)
- Potential of a no‐touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study (2014) (17)
- Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon (1998) (17)
- The regulation of glucose and lipid homeostasis via PLTP as a mediator of BAT–liver communication (2020) (17)
- Efficacy and anticarcinogenic activity of interferon for hepatitis C virus‐related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2 (2007) (17)
- Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis. A nested case-control study using 96 untreated patients. (2002) (17)
- Phase I/II study of E7080 (lenvatinib), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Initial assessment of response rate. (2012) (17)
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan (2004) (17)
- SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology (2020) (17)
- No‐touch ablation in hepatocellular carcinoma has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection (2018) (17)
- Pathogenic Significance and Organic Virus Levels in Patients Infected with TT Virus (2001) (17)
- Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen (2001) (17)
- Sustained Negativity for HCV-RNA over 24 or More Months by Long-Term Interferon Therapy Correlates with Eradication of HCV in Patients with Hepatitis C Virus Genotype 1b and High Viral Load (2004) (16)
- Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of the NS5 region (1996) (16)
- HLA‐DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy (2015) (16)
- Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. (2012) (16)
- Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C (2014) (16)
- Usefulness and limitations of balloon‐occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules (2017) (16)
- Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus (2004) (16)
- Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil (2009) (16)
- Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct‐acting antivirals regimens (2018) (16)
- Non-Destructive Evaluation Method of Pharmaceutical Tablet by Terahertz-Time-Domain Spectroscopy: Application to Sound-Alike Medicines (2013) (16)
- Benefit of Lamivudine Therapy and Factors Associated with Clinical Outcome in Spontaneous Severe Acute Exacerbation of Chronic Hepatitis B Virus Infection (2004) (16)
- Platelet-Albumin Score as a Sensitive Measure for Surgical Risk Prediction and Survival Outcomes of Patients with Hepatocellular Carcinoma (2018) (16)
- Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib (2020) (16)
- Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load. (2008) (16)
- Previous Chemoembolization Response after Transcatheter Arterial Chemoembolization (TACE) Can Predict the Anti-Tumor Effect of Subsequent TACE with Miriplatin in Patients with Recurrent Hepatocellular Carcinoma (2011) (16)
- Correlation between hepatitis B virus surface antigen level and alpha‐fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis (2014) (16)
- Diagnosis of hepatocellular carcinoma by concanavalin a affinity electrophoresis of serum alpha‐fetoprotein (1995) (16)
- Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochloride (2018) (16)
- Randomized Controlled Trial Comparing the Efficacy of Impedance Control and Temperature Control of Radiofrequency Interstitial Thermal Ablation for Treating Small Hepatocellular Carcinoma (2015) (16)
- Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine (2007) (15)
- Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs (2017) (15)
- Antiviral effect of lymphoblastoid interferon‐alpha on hepatitis C virus in patients with chronic hepatitis type C (1994) (15)
- Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy (2003) (15)
- Interferon therapy for chronic hepatitis C. (1991) (15)
- Amino Acid Substitutions in the Hepatitis C Virus Core Region and Lipid Metabolism Are Associated with Hepatocarcinogenesis in Nonresponders to Interferon plus Ribavirin Combination Therapy (2012) (15)
- Favorable efficacy of long‐term lamivudine therapy in patients with chronic hepatitis B: An 8‐year follow‐up study (2005) (15)
- Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease (2017) (14)
- In vitro approaches to evaluate placental drug transport by using differentiating JEG-3 human choriocarcinoma cells. (2011) (14)
- Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment (2005) (14)
- Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus (2017) (14)
- Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment (2010) (14)
- Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long‐term lamivudine therapy for hepatitis B e antigen‐positive chronic hepatitis B (2004) (14)
- Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients. (2011) (14)
- Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment (2004) (14)
- Potential of ultra‐highly sensitive immunoassays for hepatitis B surface and core‐related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance (2020) (14)
- Utility of Detection of Telaprevir-Resistant Variants for Prediction of Efficacy of Treatment of Hepatitis C Virus Genotype 1 Infection (2013) (14)
- [Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355(miriplatin hydrate)--safety and efficacy in combination with embolizing agents]. (2010) (14)
- Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy. (2008) (13)
- High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load (2004) (13)
- Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6 (1999) (13)
- Application of terahertz absorption spectroscopy to evaluation of aging variation of medicine. (2011) (13)
- Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus‐related liver cancer (2010) (13)
- A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus. (1998) (13)
- Efficacy of switching to entecavir monotherapy in Japanese lamivudine‐pretreated patients (2010) (13)
- Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration. (2006) (13)
- Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA. (1999) (13)
- Effectiveness and safety of reduced‐dose telaprevir‐based triple therapy in chronic hepatitis C patients (2014) (13)
- Prolonged‐efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease (2008) (12)
- Precore Wild-Type Hepatitis B Virus with G1896 in the Resolution of Persistent Hepatitis B Virus Infection (2003) (12)
- Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance (2000) (12)
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis (2004) (12)
- Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis (2001) (12)
- Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course (2000) (12)
- [Effectiveness of Ge-132 to relieve pain and smooth home care administration for the terminal cancer patient]. (1996) (12)
- Vaginal Variceal Hemorrhage in a Patient With Primary Biliary Cirrhosis: A Case Successfully Treated by Balloon-Occluded Retrograde Transvenous Obliteration (1999) (12)
- Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection (2003) (12)
- Reduction of opioid side effects by prophylactic measures of palliative care team may result in improved quality of life. (2010) (12)
- Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C (2019) (11)
- Prevention of Disease Progression with Anti-Inflammatory Therapy in Patients with HCV-Related Cirrhosis: A Markov Model (2014) (11)
- Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype B (2005) (11)
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis (2004) (11)
- Hepatocellular carcinoma metastasis to the brain mimicking primary pituitary tumor around the sella turcica (2013) (11)
- Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b (2018) (11)
- Long‐term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus‐related liver cirrhosis after interferon‐based therapy (2019) (11)
- Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNA (2015) (11)
- Randomized controlled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C (2001) (11)
- Long‐term interferon monotherapy reduces the risk of HCV‐associated hepatocellular carcinoma (2012) (11)
- Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinoma (2013) (10)
- Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C. (2008) (10)
- Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy (1999) (10)
- Evaluation of long‐term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load (2007) (10)
- Effects of Capsaicin Coadministered with Eicosapentaenoic Acid on Obesity-Related Dysregulation in High-Fat-Fed Mice. (2017) (10)
- Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma (2000) (10)
- Association of HLA-DR14 with the Treatment Response in Japanese Patients with Autoimmune Hepatitis (2010) (10)
- Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan. (2015) (9)
- TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. (2020) (9)
- A pilot study of thymosin alpha1 therapy for chronic hepatitis B patients. (2003) (9)
- Changes in viral loads of lamivudine‐resistant mutants during entecavir therapy (2007) (9)
- Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C (2004) (9)
- Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α (1999) (9)
- Real‐world effects of long‐term rifaximin treatment for Japanese patients with hepatic encephalopathy (2019) (9)
- Relationship between pretreatment viremia level and response to interferon-α therapy in chronic hepatitis c differs in viral type 1 and 2 infections (1996) (9)
- Factors associated with early cancer‐related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion (2014) (9)
- Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL (2012) (9)
- NON-ITERATIVE IDENTIFICATION OF NON-PROPORTIONALLY DAMPED SYSTEM FROM AMBIENT VIBRATION MEASUREMENT AND ANALYSIS OF DYNAMIC PROPERTIES OF A LONG SPAN SUSPENSION BRIDGE (2003) (9)
- Terahertz absorption spectra of original and generic ceftazidime. (2009) (9)
- Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load. (2003) (9)
- Polyarteritis nodosa associated with gastric carcinoma and hepatitis B virus infection. (1997) (8)
- The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2. (2009) (8)
- Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B. (1987) (8)
- Efficacy of reduction therapy of natural human β‐interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load (2012) (8)
- Ultrasensitive Assay for Hepatitis B Core‐Related Antigen Predicts Hepatocellular Carcinoma Incidences During Entecavir (2021) (8)
- Circulating MicroRNA‐122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD (2019) (8)
- Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever (2021) (8)
- Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine (2014) (8)
- Current Status of Hepatocellular Carcinoma Treatment in Japan (2012) (8)
- Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection (2015) (8)
- Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic hepatitis B patients (2002) (8)
- Origin of neovascular structure in an early stage of hepatocellular carcinoma: Study of alpha‐smooth muscle actin immunohistochemistry in serial thin sections of surgically resected cancer (2006) (8)
- Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load. (2010) (8)
- Prolonged hepatitis after acute infection with genotype H hepatitis B virus. (2007) (8)
- Usefulness of the Serum KL-6 Assay in Patients with Hepatitis C Virus (2005) (8)
- Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B (2013) (7)
- Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2 (2018) (7)
- Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study (2018) (7)
- Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy (2012) (7)
- Detection of TERT promoter mutation in serum cell‐free DNA using wild‐type blocking PCR combined with Sanger sequencing in hepatocellular carcinoma (2020) (7)
- Efficacy in Patients with Dose Reduction in Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C (2008) (7)
- Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration (1998) (7)
- New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan (2015) (7)
- A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01) (2020) (7)
- Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease (2020) (7)
- with Daclatasvir and Asunaprevir for Patients with HCV Genotype 1 b Infection and Limited Treatment Options (2012) (7)
- Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype. (2001) (7)
- Interferon retreatment of nonresponders with HCV-RNA-Positive chronic hepatitis C (1994) (7)
- [The efficacy and prognosis of transcatheter chemoembolization for hepatocellular carcinoma in the elderly]. (1999) (7)
- Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir (2014) (7)
- Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial (2018) (7)
- Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C (1995) (7)
- Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C (2009) (7)
- A Pilot Study of Thymosin α1 Therapy for Chronic Hepatitis B Patients (2003) (7)
- Biochemical and histological features of hepatitis G virus infection (1998) (7)
- Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B (1999) (7)
- Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment (2020) (7)
- Evolution of simeprevir‐resistant variants in virological non‐responders infected with HCV genotype 1b (2015) (7)
- Effect of Acute Self-Limited Hepatitis C Virus (HCV) Superinfection on Hepatitis B Virus (HBV)-Related Cirrhosis. Virological Features of HBV–HCV Dual Infection (2004) (7)
- Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma (2016) (7)
- Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT (2021) (6)
- Interferon therapy for HCV-RNA positive chronic hepatitis. (1993) (6)
- Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis (2013) (6)
- Efficacy of reduction therapy of natural human β‐interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus load (2012) (6)
- Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels (2009) (6)
- Role of NS5A-L31/Y93 Double Wild-type in Failure of Glecaprevir/Pibrentasvir Double Therapy in Two Patients with a History of Direct-acting Antiviral Agent Failure: An Ultra-deep Sequencing Analysis (2019) (6)
- Effects of the herbal medicine Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on insulin secretion and glucose tolerance in type 2 diabetic Goto-Kakizaki rats. (2010) (6)
- Influence of subtype on the prognosis of chronic type B hepatitis. (1988) (6)
- Efforts to Ensure Safety of Hospital Pharmacy Personnel Occupationally Exposed to Antineoplastic Drugs during a Preparation Task (2007) (6)
- Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses (2008) (6)
- Prevalence of HCV genotype among patients with chronic liver diseases in the Tokyo metropolitan area (1994) (6)
- Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model. (2012) (6)
- Transarterial embolization with use of lipiodol and gelatin sponge for active nasal bleeding from hepatocellular carcinoma metastasis in the pituitary gland. (2011) (6)
- Interaction between phenytoin and enteral nutrients and its influence on gastrointestinal absorption. (2019) (5)
- Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma (2016) (5)
- Circulating microRNA‐122 levels are important predictor of hepatitis B virus surface antigen seroclearance (2018) (5)
- Favorable impact of long‐term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5‐year follow‐up study (2022) (5)
- The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load. (2008) (5)
- Relationship of angiographic finding with neovascular structure detected by immunohistochemical staining of α‐smooth muscle actin in small hepatocellular carcinoma (1998) (5)
- Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C. (2001) (5)
- Long-Term Clinical Remission Induced by Corticosteroid Withdrawal Therapy (CSWT) in Patients with Chronic Hepatitis B Infection: A Prospective Randomized Controlled Trial—CSWT with and Without Follow-Up Interferon-α Therapy (2002) (5)
- What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study (2013) (5)
- Influence of HMG-CoA reductase inhibitor to virological response of peginterferon/ribavirin combination therapy in chronic hepatitis C (2008) (5)
- Virological and Biochemical Features in Elderly HCV Patients with Hepatocellular Carcinoma: Amino Acid Substitutions in HCV Core Region as Predictor of Mortality after First Treatment (2009) (5)
- Amino acid substitutions in the hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by all‐oral direct‐acting antiviral regimens (2018) (5)
- Long‐term follow up of peginterferon‐α‐2a treatment of hepatitis B e‐antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies (2016) (5)
- Characterization of multidrug resistance-associated protein mRNAs expression profiles in Caco-2 and HT-1080 cell lines induced by methotrexate. (2008) (5)
- Serum levels of gamma-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection. (2003) (5)
- Cholangiolocellular Carcinoma in a Young Patient Who Showed Sustained Virological Response after Treatment for Hepatitis C Virus Infection (2017) (4)
- Influence of gender to efficacy of interferon/ribavirin combination therapy in chronic hepatitis C patients in Japan (2007) (4)
- Transcatheter Arterial Chemotherapy with Miriplatin for Hepatocellular Carcinoma Patients with Chronic Renal Failure: Report of Three Cases (2013) (4)
- Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer—A pilot study (1997) (4)
- Assessment of palliative care team activities--survey of medications prescribed immediately before and at the beginning of opioid usage. (2008) (4)
- PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD (2021) (4)
- Magnetic resonance laparoscopy: A new non‐invasive technique for the assessment of chronic viral liver disease (2013) (4)
- Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma (2017) (4)
- Effects of the herbal medicine goshajinkigan on sucrose-rich diet-induced hypertriglyceridemia in rats (2009) (4)
- Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavir (2021) (4)
- Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection (2017) (4)
- Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic rats. (2007) (4)
- Fulminant Hepatitis due to de novo Hepatitis B after Cord Blood Transplantation Rescued by Medical Treatment (2020) (4)
- Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B (2007) (4)
- Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. (2020) (4)
- A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels (1996) (4)
- Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus load. (2009) (4)
- Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy. (2002) (4)
- Inhibitory activity on murine granulocytic colony formation of bone marrow cell-conditioned medium obtained from colony-stimulating factor-producing tumor-bearing nude mice. (1984) (4)
- Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients. (2002) (4)
- Discrimination of fibrotic staging of chronic hepatitis C using multiple fibrotic markers (2014) (4)
- Genotypical classification of hepatitis C virus genome isolated from Japanese patients with chronic hepatitis type C. (1992) (4)
- Hepatocellular carcinogenesis after elimination of hepatitis C virus-RNA by interferon therapy (2007) (4)
- Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease (2020) (4)
- Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases (2010) (3)
- Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus. (2014) (3)
- Frequency of HCV antibody who has non-A non-B chronic liver disease both or one side spouse. (1990) (3)
- The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis (1997) (3)
- A long-term prognosis after interferon therapy for chronic hepatiti C (1996) (3)
- Effects of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on hyperinsulinemia induced in rats fed a sucrose-rich diet. (2011) (3)
- [Current therapy for hepatocellular carcinoma]. (2010) (3)
- G13 : Ombitasvir/paritaprevir/ritonavir for treatment of HCV genotype 1b in Japanese patients with or without cirrhosis: Results from gift-I (2015) (3)
- An encapsulated bulky abdominal abscess due to amoeba (2021) (3)
- [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer]. (1985) (3)
- Effect of lymphoblastoid alfa-interferon in patients with chronic hepatitis C having different genotypic subtype of hepatitis C virus (1993) (3)
- Efficacy and Anticarcinogenic Activity of Ribavirin Combination Therapy for Hepatitis C Virus-Related Compensated Cirrhosis (2012) (3)
- Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection (2006) (3)
- Changes of intestinal mucosal and plasma PYY in a diarrhea model rat and influence of loperamide as the treatment agent for diarrhea. (2008) (3)
- Carrier-mediated placental transport of cimetidine and valproic acid across differentiating JEG-3 cell layers. (2015) (3)
- Hepatitis G virus infection after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma (1997) (3)
- Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy (2004) (3)
- Novel hepatitis B variants in sibling carriers positive for antibody to hepatitis B surface antigen (1995) (3)
- Long-Term Follow-Up of HBeAg-Positive Young Adult Japanese Patients Treated with Corticosteroid Withdrawal Therapy for Chronic Hepatitis B (2006) (3)
- Upgrading a Pharmaceutical Information System for Preparation of Parenteral Admixtures for Ambulant Chemotherapy in a Hospital Pharmacy Using End-user Prototype Model, and Comprehensive Evaluation of Upgraded System (2006) (3)
- Genotyping of hepatitis C virus by the polymerase chain reaction: a comparison of two PCR-based methods using core or NS5 primers (1995) (3)
- HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B (2003) (3)
- A case of well-differentiated hepatocellular carcinoma larger than 40mm in diameter. (1993) (3)
- Undifferentiated carcinoma of the liver demonstrated by contrast-enhanced ultrasonography (2020) (3)
- [Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect]. (1988) (3)
- Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma. (2015) (3)
- [Long-term prognosis of liver cirrhosis]. (1994) (2)
- Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort study (2021) (2)
- Interferon therapy on chronic type B hepatitis, defined as anti-HBe positive chronic liver disease with elevated transminases. (1990) (2)
- [Repeated transcatheter arterial embolization therapy of hepatocellular carcinoma]. (1986) (2)
- Localization of glucagon-like peptide-2 receptor mRNA expression at different sites in the small intestine of rats. (2008) (2)
- A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment Who Developed Inclusion Body Myositis (2018) (2)
- [Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin]. (2010) (2)
- [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy]. (1986) (2)
- The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load. (2008) (2)
- [The diagnosis of hepatocellular carcinoma determined by pattern of AFP bands separated by Con A affinity electrophoresis]. (1994) (2)
- [Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]. (2011) (2)
- Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotype (1998) (2)
- [Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function]. (1987) (2)
- A case of hepatocellular carcinoma presenting regression of bone Metastases in the course of transcatheter arterial embolization therapy. (1986) (2)
- Long-term follow-up of mitomycin C nephropathy. (1994) (2)
- Dynamics of Circulating miR-122 Predict Liver Cancer and Mortality in Japanese Patients with Histopathologically Confirmed NAFLD and Severe Fibrosis Stage (2021) (2)
- Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics. (1980) (2)
- Relationship between Five-Year Histological Outcome and Serial Changes in Serum Alanine Aminotransferase in Patients with Biochemical and Virological Relapse after Interferon Treatment for Chronic Hepatitis C (2000) (2)
- New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease (2017) (2)
- A case of ezetimibe-effective hypercholesterolemia with a novel heterozygous variant in ABCG5. (2020) (2)
- Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin. (2007) (2)
- Endoscopic Regression and Evaluation of Injection Sclerotherapy for Esophageal Varices in Case of Hepatocellular Carcinoma with Portal Vein Invasion. (1996) (2)
- Research on Present Situation and Recognition of Palliative Treatment and Narcotic Analgesics in Pharmacists Working for Pharmacies (2009) (2)
- hepatocarcinogenesis following eradication of HCV RNA (2015) (2)
- Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis (1992) (2)
- Safety and efficacy of lenvatinib by starting dose (8 mg or 12 mg) based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. (2019) (2)
- The Efficacy of 24-Week Interferon Monotherapy for Type C Liver Cirrhosis in Japanese Patients with Genotype 1b and Low Virus Load (2008) (2)
- Treatment efficacy of all-oral combinations of direct-acting antivirals in chronic hepatitis C patients with NS5A-P32 deletion (2017) (2)
- Correlation of Histopathological Features andGenetic Variations with Prognosis of JapanesePatients with Nonalcoholic Fatty Liver Disease (2016) (2)
- A Research Survey on Implementation Situation of Home Medical Care, Pharmacists^|^rsquo; Attitudes and Opinions in Community Pharmacies (2012) (2)
- Hepatitis C virus subtype 3b infection in a hospital in Japan: Epidemiological study (1996) (2)
- Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation (2004) (2)
- [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy]. (2007) (2)
- Clinicopathological assessment of steatohepatitic hepatocellular carcinoma. (2021) (2)
- Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma (2022) (2)
- Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment (2021) (2)
- Clinicopathological improvement of non‐alcoholic steatohepatitis associated with weight loss during a 14‐year follow‐up period (2007) (2)
- Clinical significance of hepatectomy for primary biliary cirrhosis patients with hepatocellular carcinoma: Report of a single center case series and review of the published work (2014) (2)
- The usefulness of HCV antibody titers in interferonn therapy (1990) (2)
- [Successful treatment of hepatic metastasis of gastric cancer with 5'-DFUR and Lentinan]. (1998) (2)
- Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal Liver (2019) (2)
- Two operated cases of small bowel metastases from primary lung cancer. (1990) (1)
- Phase I/II Trial of Lenvatinib (E7080), A Multi-Targeted Tyrosine Kinase Inhibitor, in Patients (PTS) with advanced Hepatocellular Carcinoma (HCC) (2012) (1)
- Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer (1999) (1)
- Early diagnosis of small hepatocellular carcinoma with PIVKA-II determined by Abidin-Biotin complex method. (1993) (1)
- Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease (2019) (1)
- Two cases receiving retreatment with 12 weeks of glecaprevir and pibrentasvir for HCV genotype 2 infection who failed prior glecaprevir and pibrentasvir therapy (2021) (1)
- Long-term observation of four patients with early stage of primary biliary cirrhosis(PBC). (1997) (1)
- Effect of interferon therapy on viral titers in patients with chronic hepatitis C who are positive for hepatitis GB virus C. (1997) (1)
- Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis. (1998) (1)
- The non-effect of anti-interferon alpha-2a antibody on the response to inerferon therapy. (1996) (1)
- Independent imaging review (IIR) results in a phase 3 trial of lenvatinib (LEN) versus sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2018) (1)
- Incidence of seroconversion in e antigen-antibody system and e antigen-reappearance in chronic hepatitis type B. (1984) (1)
- Heterogeneous circulating miRNA profiles of PBMAH (2022) (1)
- Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies. (2003) (1)
- Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long‐term other nucleotide analog treatment in patients with chronic hepatitis B (2021) (1)
- [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer]. (1998) (1)
- The Impact of Lenvatinib on Tumor Blood Vessel Shrinkage of Hepatocellular Carcinoma during Treatment: An Imaging-Based Analysis (2022) (1)
- A novel entecavir-resistant virus with patient of lamivudine-resistant hepatitis B virus mutant (2005) (1)
- Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease (2022) (1)
- [A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma]. (1984) (1)
- Forefront of radiofrequency ablation treatment of hepatic cancer. 2. Comparison of the equipment for radiofrequency ablation therapy. (2005) (1)
- ASSET EVALUATION OF EACH BRIDGE MEMBER AND ANALYSIS OF BRIDGE HEALTH INDEX (BHI) (2002) (1)
- Viscosity Changes Using Semi-solidifying Materials and the Dissolution Behavior of a Drug in Enteral Nutrition (2012) (1)
- Erratum to: Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers (2013) (1)
- Elaborate designs with artisan spirit to treat liver cancer in Japan (2012) (1)
- Long term follow-up of glycyrrhizin therapy in patients with chronic hepatitis C and non-response to interferon: Meta-analysis of individual patient data (2003) (1)
- [Hepatocellular carcinogenesis and prognosis of elderly patients with chronic hepatitis type C]. (2001) (1)
- Lipiodol and Dye at the Site of Ablation Decreases during RFA (2009) (1)
- A case of drug-induced acute liver failure caused by corticosteroids (2022) (1)
- [Remission state and five-year survival after transcatheter arterial embolization therapy in patients with hepatocellular carcinoma]. (1989) (1)
- CASE REPORT: Interferon-α for Reinfection with Hepatitis C Virus in Two Patients with Chronic Hepatitis C Who Had Responded to Previous Therapies (2003) (1)
- The useful predictors of zinc deficiency for the management of chronic liver disease (2022) (1)
- Positive rate of C-100 antibody and changes of long term follow up cases of chronic liver disease. (1991) (1)
- [Clinical features and viral markers in patients with chronic hepatitis positive for both HBs antigen and anti-C-100 antibody]. (1991) (1)
- Approach for differentiating trophoblast cell lineage from human induced pluripotent stem cells with retinoic acid in the absence of bone morphogenetic protein 4. (2018) (1)
- Subject Index Vol. 49, 2006 (2006) (0)
- [A case of recurrent hepatitis with eosinophilia and eosinophilic infiltration in the liver]. (1985) (0)
- Contents Vol. 51, 2008 (2009) (0)
- Proceedings of the 24th autumn meeting from October 14–16, 1982-Yamagata City, Japan (2007) (0)
- Comparison between Lumipulse Presto HBsAg-HQ and iTACT-HBsAgin Chronic Hepatitis B with Seroclearance of HBsAg by Architect HBsAg QT (2021) (0)
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analogues treatment in chronic hepatitis B (2011) (0)
- Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma (2022) (0)
- Effectiveness of systemic chemotherapy using CBDCA and 5-FU in a case of hepatocellular carcinoma with metastases to the lung (2011) (0)
- Contents Vol. 52, 2009 (2009) (0)
- Locoregional therapy for hepatocellular carcinoma. (2005) (0)
- Impact of bodyweight (BW)-based starting doses on safety and efficacy of lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC). (2021) (0)
- [Evaluation of peritoneal lavage smears and intraperitoneal administration of anti-neoplastic agents in stage III and IV gastric cancer]. (1998) (0)
- [A questionnaire survey for pharmacists participating in a home medical care training workshop]. (2012) (0)
- Contents Vol. 86, 2014 (2014) (0)
- Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors. (2023) (0)
- Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-years (2020) (0)
- [Less invasive medical therapy for hepatocellular carcinoma]. (2001) (0)
- [Radical and multimodality therapy for hepatitis C virus-related hepatocellular carcinoma]. (1995) (0)
- Abstracts of selected papers presented at the 28th Annual Meeting of the Japanese Society of Gastroenterology Kanazawa, Japan, October 1–3, 1986 (1987) (0)
- Effect of IFN therapy and amino acid substitutions in the hepatitis C virus (HCV) core region on hepatocarcinogenesis in HCV-related cirrhotic patients. (2010) (0)
- A case of small cell lung cancer with metastases to the stomach. (1989) (0)
- A study of prolonged absence of both eAg and eAb(e-window) in hepatitis B. (1987) (0)
- Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting Antivirals (2022) (0)
- Low hepatitis B virus core-related antigen is a predictor of absence in post-treatment recurrence of hepatocellular carcinoma during antiviral therapy (2009) (0)
- Changes in the Mean Intrahepatic Target Computed Tomography Attenuation Value During Treatment May Be a Useful New Predictor of the Post-progression Survival Associated with Lenvatinib Treatment (2021) (0)
- [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin]. (1992) (0)
- [Current status of treatment for HBV-related cirrhosis]. (2004) (0)
- Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs (2021) (0)
- [A case of intrahepatic cholangiocarcinoma with liver cirrhosis presenting atypical images]. (1992) (0)
- Electrocardiographic changes during injection sclerotherapy. (1988) (0)
- 微粒子分散物、これを用いたインク、及びインクジェット記録方法 (2004) (0)
- Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection (2015) (0)
- Contents Vol. 55, 2012 (2012) (0)
- Pharmacokinetics of Loxoprofen and Cefcapene following a Single Combined Dose in Healthy Volunteers before, during or Immediately after 120-min Enteral Tube Feeding of 400 mL Ensure Liquid® (2017) (0)
- Polymorphism control of pharmaceutical compound indomethacin by femto-second laser induced nucleation (2013) (0)
- Increase of rtA181T mutant strains during entecavir therapy for a patient with chronic hepatitis B virus infection (2010) (0)
- Quantitative analysis of hepatitis C virus RNA by competitive nested polymerase chain reaction. Comparison of various internal standard. (1994) (0)
- Abstracts of selected papers presented at the 33rd Annual Meeting of the Japanese Society of Gastroenterology (2007) (0)
- Pretreatment heterogeneous enhancement pattern of hepatocellular carcinoma can be new predictor for early response to lenvatinib (2019) (0)
- Effect of early antiviral agent therapy (NS3 and NS5A inhibitors) in chronic hepatitis C null responders (2011) (0)
- Diagnosis of small hepatic nodular lesion determined by magnetic resonance imaging (MRI) under breath holding (1996) (0)
- P-21 Genetic drift of hepatitis B virus precore/core region in long-term follow-up of asymptomatic HBe-Ag-positive carriers (1995) (0)
- [Cranial MRI in the patients with chronic liver disease (CLD)]. (1997) (0)
- Potential impact of joint association of alanine aminotransferase and gamma‐glutamyltransferase on insulin resistance in Japan: The Toranomon Hospital Health Management Center Study 19 (TOPICS 19) (2015) (0)
- Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
- The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired Biopsies (2019) (0)
- Contents Vol. 49, 2006 (2006) (0)
- Noninvasive Assessment of Fat and Iron Deposition in the Liver by PDFF and T2* Measurement Using the 6-Point DIXON Method (2019) (0)
- Hepatitis B core-related antigen and viral loads status impacts on the risk of hepatocellular carcinoma in patients with HBeAg-negative chronic hepatitis B virus infection (2020) (0)
- ’ s response to reviews Title : Portal vein thrombosis in liver cirrhosis : Incidence , management , and outcome (2017) (0)
- Front & Back Matter (2012) (0)
- Changes of HBV DNA after seroconversion from hepatitis B e antigen to anti-HBe after corticosteroid withdrawal therapy. (1991) (0)
- Hepatocellular carcinoma in noncirrhotic patient (1986) (0)
- [Study on the family clustering of non-A, non-B chronic hepatitis]. (1988) (0)
- Seroconversion from HBs-Ag to anti-HBs in a case of liver cirrhosis associated with hepatocellular carcinoma. (1987) (0)
- P-502 Influence of interferon administration on hepatocellular carcinogenesis from viral cirrhosis (1995) (0)
- Subject Index Vol. 48, 2005 (2005) (0)
- [Hepatocellular carcinogenesis in type B liver cirrhosis]. (1995) (0)
- [Non-Hodgkin's malignant lymphoma with central nervous involvement--report of 7 cases]. (1983) (0)
- Reply (2001) (0)
- Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma (2022) (0)
- Changes of laparoscopic histological findings in three cases of chronic hepatitis-B treated with Lamivudine. (1998) (0)
- Efficient Loading of cisplatin into Superabsorbent Polymer Microsphere in the treatment of hepatocellular carcinoma. (2015) (0)
- [Seven cases of acute exacerbation accompanied with icterus and ascites in chronic type B hepatitis]. (1989) (0)
- Identification and Quantification Method for UCN2 by LC/MS/MS from Plasma/Serum from Mouse Disease Models (2020) (0)
- Relationship of hepatic arterial spasm to obstruction of main hepatic artery trunk after transcatheter arterial embolization for hepatocellular carcinoma. (1984) (0)
- Contents Vol. 47, 2004 (2004) (0)
- Subject Index Vol. 52, 2009 (2009) (0)
- [Recent advances in the treatment of hepatocellular carcinoma]. (2015) (0)
- GASTRODUODENAL LESIONS AS COMPLICATIONS OF TRANSCATHETER ARTERIAL EMBOLIZATION THERAPY FOR HEPATOCELLULAR CARCINOMA (1988) (0)
- Contents Vol. 48, 2005 (2005) (0)
- Proceedings of the 69th General Meeting from April 11–13, 1983-Osaka, Japan (1984) (0)
- A new classification of dynamic CT images predictive of malignant characteristics of hepatocellular carcinoma. (2010) (0)
- Subject Index Vol. 51, 2008 (2009) (0)
- Effect of Vial shaking on Loading Time of Epirubicin into Drug-Eluting Bead (2015) (0)
- A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices (1999) (0)
- Studies on the family of HBs positive antigen whose different subtypes existing in the same family. (1989) (0)
- Usefulness of diet and exercise program for fatty liver-Trial of "Hospitalization program for improvement purpose for the fatty liver" (2023) (0)
- Acknowledgement to reviewers (2015) (0)
- Repression of Adipose Tis sue Fibrosis through a PRDM 16-GTF 2 IRD 1 Complex Improves Systemic Glucose Homeostasis Graphical Abstract Highlights (2018) (0)
- Protective effects by co-administration of eicosapentaenoic acid, capsaicin, and dextrin against obesity-related metabolic dysregulation in ob/ob mice (2018) (0)
- Relationships between HCV genotype and serological group in patients, except for genotype 1 or 2 (2018) (0)
- [Effects of intravenous and oral administration of ondansetron hydrochloride on chemotherapy-induced nausea and vomiting in patients with esophageal cancer]. (1999) (0)
- Histological impact at 5 years after the start of sodium-glucose cotransporter 2 inhibitor for non-alcoholic steatohepatitis complicated by diabetes mellitus (2021) (0)
- Combination therapy with transcatheter arterial infusion chemotherapy using miriplatin and percutaneous radiofrequency ablation for hepatocellular carcinoma (2012) (0)
- SUCCESSFUL HEMOSTASIS WITH OCTREOTIDE FOR BLEEDING FROM ULCERS DEVELOPING AFTER ENDOSCOPIC VARICEAL LIGATION ; REPORT OF TWO CASES (1997) (0)
- The Environmental Assessment by the Air Cleanliness of the Drug Preparation Room in the Hospital Pharmacy and the Analysis of Influential Factors to Airborne Particle Number. (2001) (0)
- EŠects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on Intestinal Function in Streptozotocin-induced Diabetic Rats (2007) (0)
- Significance of hepatitis B virus subtype and hepatitis C virus subtype in the prognosis of liver cirrhosis (1994) (0)
- Change of Editorship 2012 (2012) (0)
- [Prevention of hepatocellular carcinogenesis by interferon]. (2001) (0)
- Impact of sodium-glucose co-transporter 2 inhibitor for non-alcoholic fatty liver disease complicated by diabetes mellitus -Prospective study based on the serial liver biopsy- (2016) (0)
- Evaluation of Stability after Opening Packages and Dispensing When Using Automatic Tablet-Packing Machine for Orally Disintegrating Tablets of Tamsulosin Hydrochloride (2012) (0)
- [Study on frequency of the eAg-eAb seroconversion by corticosteroid and glycyrrhizin in eAg positive chronic hepatitis (author's transl)]. (1981) (0)
- INFLUENCE OF TRANSCATHETER ARTERIAL EMBOLIZATION THERAPY ON ESOPHAGOGASTRIC VARICES IN PATIENT WITHHEPATOCELLULAR CARCINOMA (1986) (0)
- Role of mother-to-child and father-to-child transmission of hepatitis B virus for establishing a carrier state in children. (1986) (0)
- Subject Index Vol. 47, 2004 (2004) (0)
- [Evaluation of transcatheter arterial embolization therapy for hepatocellular carcinoma]. (1984) (0)
- Protective EŠects of Lactoferrin against Intestinal Mucosal Damage Induced by Lipopolysaccharide in Human Intestinal Caco-2 Cells (2008) (0)
- [Clinical features of hepatitis C virus-related liver cancer]. (1995) (0)
- [Two cases of inoperable advanced bileduct cancer treated effectively with a gemcitabine/cisplatin combination]. (2009) (0)
- Contents Vol. 91, 2016 (2016) (0)
- Analysis of .ALPHA.-Fetoprotein separated by agarose-gel affinity electrophoresis discrimination of hepatocellular carcinoma. (1992) (0)
- [A case of overlap syndrome with polymyositis and progressive systemic sclerosis associated with acute renal failure due to myoglobinuria]. (1988) (0)
- In vitro approach for placental drug transport studies using induced pluripotent stem cells (2017) (0)
- A study of six patients with exacerbated chronic hepatitis B after seroconversion from HBe antigen to anti-HBe by short term corticosteroid withdrawal therapy. (1988) (0)
- [Anti-viral treatment for liver cirrhosis]. (2010) (0)
- Infection Treatment of Hepatitis C Virus Genotype 1 Variants for Prediction of Efficacy of Utility of Detection of Telaprevir-Resistant (2013) (0)
- 1. Selection of Evidence-based Therapeutic Policy (2008) (0)
- The effect of interferon administration on the patients with chronic hepatitis type C. (1991) (0)
- A histological study of HBV carriers with e-antigen positive and normal range of transaminase. (1990) (0)
- Subgroup analyses of a phase 1/2 study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC). (2017) (0)
- The efficacy of prolonged natural interferon-.ALPHA. therapy for chronic hepatitis C. (1997) (0)
- High Virus Titer, Slow Virus Decrease, Genotype II, and Sequence Variability of E2/NS1 HVR Predict Poor Response to Interferon Therapy in Chronic Hepatitis C (1994) (0)
- Comparisons of three methods extracting HCV RNA from serum and primers for cDNA synthesis. (1992) (0)
- Cover Image, Volume 92, Number 12, December 2020 (2020) (0)
- An autopsied case of hepatocellular carcinoma associated with a skin invasion via ligamentum teres hepatis. (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Kenji Ikeda?
Kenji Ikeda is affiliated with the following schools:
